A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors
- 1 December 1993
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (6) , 1150-1156
- https://doi.org/10.1038/bjc.1993.496
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.Journal of Clinical Oncology, 1993
- Management of small-cell cancer of the lungThe Lancet, 1992
- An overview of prognostic factors in small cell lung cancerBritish Journal of Cancer, 1990
- Duration of chemotherapy in small cell lung cancer.Thorax, 1990
- Patients at risk of chemotherapy-associated toxicity in small cell lung cancerBritish Journal of Cancer, 1989
- Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trialBritish Journal of Cancer, 1989
- Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancerCancer, 1987
- Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trialCancer Chemotherapy and Pharmacology, 1986